Subjects and methods: Sixty patients undergoing endoscopic retrograde cholangiopancreatography between July 2019 and September 2020 were consecutively enrolled, and their demographics, laboratory data, and CBD stone-related characteristics according to PAD type and PAD size were analyzed.